Invasive aspergillosis affects 3 to 11% of BMT patients with a high mortality rate (60 to 95%). Extra-pulmonary disease is an unusual event, and primary renal aspergillosis is extremely uncommon. A patient with CML treated with BMT, who developed primary renal and subsequently hepatic aspergillosis, is described. Dysfunction of the mucosal barrier secondary to conditioning therapy, was a possible portal of entry for the fungus. Fine needle aspiration was very useful, as is direct microscopic examination of the urine, for diagnosis of the fungal infection. Surgical drainage of the abscess followed by antifungal therapy is the treatment of choice. Unconducive situations, such as refractory thrombocytopenia, are associated with the worst outcome in these patients. Keywords: bone marrow transplantation; primary renal aspergillosis; disruption of mucosal barrier; fine needle aspiration; surgical approach; antifungal therapy Invasive aspergillosis is a devastating infection that affects mainly immunocompromised hosts. Between 3 and 11% of BMT patients develop Aspergillus infections, especially with A. fumigatus and A. flavus.
Invasive aspergillosis is a devastating infection that affects mainly immunocompromised hosts. Between 3 and 11% of BMT patients develop Aspergillus infections, especially with A. fumigatus and A. flavus. 1, 2 Primary renal aspergillosis is extremely uncommon; only 23 cases have previously been described in the literature and four of these are in AIDS patients. 3 We report a case of primary renal aspergillosis with extension to the liver in a BMT patient, which is, as far as the authors know, the first reported case.
Case report
A 49-year-old male with CML in chronic phase, with a good performance status and no previous infection history, received an HLA-identical allogeneic BMT. He was conditioned with busulphan 4 mg/kg p.o. in divided doses daily for 4 days (total dose 16 g/kg) and cyclophosphamide 60 mg/kg daily i.v. on days 1 and 2 (total dose 120 g/kg). Immunoprophylaxis of GVHD was with cyclosporin A, methotrexate and prednisone. On day +7, mucositis grade III was noticed. On day +16, he developed abdominal pain and ultrasound revealed a stone in the right renal pelvis, with no evidence of urinary obstruction. On day +29, hematuria was noticed, followed by passage of the renal stone. On examination this was demonstrated to be composed of aspergillus. Direct microscopic examination of the urine showed fragments of hyaline and septate hyphae, also suggestive of aspergillus, with A. fumigatus growing on urine culture. Amphotericin B (1 mg/kg/day) was started. An abdominal CT scan was carried out a week later because of persisting abdominal pain. This revealed hypodense lesions in both kidneys. The liver also had a hypodense lesion contiguous to the right kidney abscess, most likely due to direct extension from the renal lesion ( Figure 1 ). An extensive study was carried out, including CT scan of lungs and sinuses, looking for the portal of entry of the fungus which was not identified. Culture of the fine needle aspiration material from both renal and hepatic lesions revealed fungal growth, confirming the diagnosis of renal and hepatic aspergillosis by A. fumigatus. Amphotericin B was progressively increased to 2 mg/kg/day. At this time, granulocytic recovery was satisfactory, but platelets never reached 40 × 10 9 /l. Open surgical drainage of the abscesses was refused by the patient, because of the high risk due to thrombocytopenia refractory to platelet transfusion. His renal function deteriorated, cyclosporin A had to be stopped and regular amphotericin B was switched to a liposomal formulation. On day +76, a diffuse cutaneous rash established the diagnosis of acute graft-versus-host disease, and methylprednisolone was started. On day +139, disseminated nodules, probably fungal in origin, were detected in both lungs. On day +142 the patient expired due to respiratory failure.
Discussion
The most common species of Aspergillus implicated in human disease is A. fumigatus, and BMT patients are particularly prone to infection with this fungus. Predisposing factors, such as neutropenia, disruption of mucosal barriers, broad-spectrum antimicrobial agents, immunosuppressive effects of prophylaxis and treatment of GVHD and GVHD by itself, are found among these patients. [2] [3] [4] The therapy is often unsuccessful and mortality of invasive infection ranges from 60 to 95%. 5 The nasal passages, sinuses and the respiratory tract are the main portal of entry for this organism, and a pulmonary infiltrate with a surrounding halo zone of decreased attenuation, the 'halo sign', is characteristic of aspergillosis. Hematogenous dissemination from the primary pulmonary infection is frequent, with successive involvement of many organs including the kidneys, which at autopsy are involved in 8 to 12% of cases. 4, 5 Ascending infection through the urinary tract, 6 and renal contamination through direct introduction of fungus are possible routes of kidney infection. 7 Sporadic reports of invasive aspergillosis from primary cutaneous infection 8 or following contamination of an area of epidermolysis 9 have been reported. Aspergilli have been isolated from normal gastrointestinal tract, and systemic infection has been reported without any evident portal of entry, suggesting that infection may occur by the oral route. 10 The portal of entry of the fungus in our patient was not identified, despite extensive clinical and radiological studies. We can speculate that the fungus reached the circulation from the gastrointestinal tract, after disruption of the intestinal mucosal barrier caused by the conditioning regimen.
Kidney involvement in primary renal aspergillosis is usually unilateral and only in four cases reported were both kidneys implicated. 3 Renal parenchymal invasion has rarely been reported and mostly fungi are located along the excretory system, with an obstructive clinical presentation produced by the fungus ball.
11
The parenchyma of both kidneys and liver of our patient were involved, as confirmed by fine needle aspiration which is a reasonable method of diagnosing invasive fungal lesions. 12 This ratified the previous finding of aspergillus in urine and renal casts. Direct extension from adjacent structures is a well-known etiology for liver abscesses, easily explaining the liver involvement of our patient.
Hematuria following BMT occurs in 4% to 25% of transplant patients, mainly relating to cyclophosphamide in high doses and various virus. 13 The hematuria and kidney stone called our attention to the diagnosis of fungal invasion of the kidneys, being an incentive to look for aspergillus in the urine. In our patient, the liver and kidney abscesses were only partially controlled after fine needle drainage and systemic treatment with amphotericin B. Surgical drainage of the abscess followed by amphotericin B is the treatment of choice in renal aspergillosis, as previously shown in AIDS patients and drug addicts. 9, 14 In conclusion, primary renal aspergillosis is an extremely uncommon entity, particularly post-BMT. Adequate management includes antifungal therapy and surgical drainage, which may be difficult in refractory thrombocytopenic patients. Furthermore, renal aspergillosis must be considered in the differential diagnosis of hematuria and kidney stones following BMT.
